Research.Patient.info
CDKL5 Deficiency Disorder research hub
2 indexed studies · 0 currently recruiting
- active not recruitingPHASE3
A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder.
United States · Austria · Belgium - ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2, Prospective, Interventional, Open-Label, Multisite, Extension Study to Assess the Long-Term Safety and Tolerability of Soticlestat (TAK-935) as Adjunctive Therapy in Subjects with Developmental Epileptic Encephalopathies Including Dravet Syndrome, Lennox Gastaut Syndrome, CDKL5 Deficiency Disorder, and Chromosome 15 Duplication Syndrome (ENDYMION 1)
Spain · Portugal · Poland